BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16453335)

  • 21. Safety of hematopoietic stem cell transplantation in children less than three years of age.
    Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
    Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
    Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
    Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High incidence of radiation-induced cavernous hemangioma in long-term survivors who underwent hematopoietic stem cell transplantation with radiation therapy during childhood or adolescence.
    Koike T; Yanagimachi N; Ishiguro H; Yabe H; Yabe M; Morimoto T; Shimizu T; Takakura H; Kato S
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1090-8. PubMed ID: 22198541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group.
    Faraci M; Bagnasco F; Corti P; Messina C; Fagioli F; Podda M; Prete A; Caselli D; Lanino E; Dini G; Rondelli R; Haupt R;
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1271-6. PubMed ID: 19747635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
    Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
    Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
    Bishop MM; Beaumont JL; Hahn EA; Cella D; Andrykowski MA; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
    J Clin Oncol; 2007 Apr; 25(11):1403-11. PubMed ID: 17416860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation.
    Brand HS; Bots CP; Raber-Durlacher JE
    Br Dent J; 2009 Nov; 207(9):E17; discussion 428-9. PubMed ID: 19893563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study.
    Shankar SM; Carter A; Sun CL; Francisco L; Baker KS; Gurney JG; Weisdorf DG; Forman SJ; Robison LL; Grant M; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):834-9. PubMed ID: 17416780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C; Meijer E; Petersen EJ; Lokhorst HM; Verdonck LF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies.
    Shah AJ; Epport K; Azen C; Killen R; Wilson K; De Clerck D; Crooks G; Kapoor N; Kohn DB; Parkman R; Weinberg KI
    J Pediatr Hematol Oncol; 2008 Jun; 30(6):411-8. PubMed ID: 18525456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term endocrine sequelae of childhood cancer.
    Rutter MM; Rose SR
    Curr Opin Pediatr; 2007 Aug; 19(4):480-7. PubMed ID: 17630615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.
    Baker KS; Bresters D; Sande JE
    Pediatr Clin North Am; 2010 Feb; 57(1):323-42. PubMed ID: 20307723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia.
    Lowe T; Luu T; Shen J; Bhatia S; Shibata S; Stein A; Somlo G
    Onkologie; 2008 May; 31(5):266-9. PubMed ID: 18497517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.